Evidence map›Paper›PMID 40844760›Full record

ReviewRheumatology international2025

The role of mesotherapy in chronic back pain syndrome: what do we know?

Kamil Koszela, Massimo Mammucari, Michał Słupiński, Marta Woldańska-Okońska

Abstract readReview
In one paragraph

Review in Rheumatology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kamil KoszelaDepartment of Neuroorthopedics and Neurology Clinic and Polyclinic, National Institute of Geriatrics, Rheumatology and Rehabilitation in Warsaw, Warsaw, 02-637, Poland. kamil.aikido@interia.pl.ORCID http://orcid.org/0000-0003-3629-7523
Massimo MammucariClinical Pharmacology and General Practice-ASL, Rome, Italy.ORCID http://orcid.org/0000-0002-9515-3549
Michał SłupińskiRehabilika-Centre for Rehabilitation and Adult Age Medicine, Lodz, 93-029, Poland.ORCID http://orcid.org/0000-0003-0999-8885
Marta Woldańska-OkońskaDepartment of Internal Medicine, Rehabilitation and Physical Medicine, Medical University of Lodz, Lodz, 90-419, Poland.ORCID http://orcid.org/0000-0003-2884-2229

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Back pain syndrome is one of the most prevalent disorders of the 21st century, frequently diagnosed by physicians across various medical specialties. A key clinical priority is to identify the underlying cause and establish an accurate diagnosis. A common etiological factor is the overload of soft tissues due to improper posture or movement, resulting in congestion, reduced mobility, and pain. Spinal mesotherapy, a minimally invasive injection technique, has gained attention for its ability to improve microcirculation, relax tense tissues, enhance range of motion, and, most importantly, alleviate pain. Increasingly, this treatment is being incorporated into a structured "three-step approach" to chronic back pain: risk factor assessment, medical intervention (such as spinal mesotherapy), and subsequent targeted physiotherapy. This narrative review analyzes nine studies involving more than 800 patients with chronic back pain syndrome. Across all included studies, mesotherapy demonstrated a consistent positive impact on both pain reduction and functional improvement, without reports of serious adverse events. The purpose of this review is to assess the current evidence on the efficacy and safety of spinal mesotherapy and to highlight its role within a multimodal treatment strategy for chronic back pain.

Indexed as

Back PainChronic PainMesotherapyHumansPhysical Therapy ModalitiesTreatment OutcomeBack painInjectionPainSpine

Identifiers

PMID40844760
PMCPMC12373703

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.